Comments on Matthew J. Kling's articles Comments on Matthew J. Kling's articles RSS Syndication from SeekingAlpha.com http://seekingalpha.com/author/matthew-j-kling/articles China Medical: A Cure For My Portfolio? http://seekingalpha.com/article/59223/comments?source=feed#comment-122758 122758 Wed, 05 Mar 2008 23:55:52 -0500
Not to mention that there aren't any real competitors to this company... they are at the top of their class. The downward trend has been nothing short of amazing and it is below the 200 SMA now. ]]>
China Medical: A Cure For My Portfolio? http://seekingalpha.com/article/59223/comments?source=feed#comment-122231 122231 Wed, 05 Mar 2008 00:28:34 -0500
Thanks for the correction I should have said it as you said, "in 2003...forecast..."

Matt]]>
China Medical: A Cure For My Portfolio? http://seekingalpha.com/article/59223/comments?source=feed#comment-121801 121801 Tue, 04 Mar 2008 02:29:35 -0500 reports.manta.com/data...) Nonetheless, there’s no doubt that this market is growing fast and will continue to do so.

I found the most interesting part of that report to be China’s demographic shift, i.e. ageing population. According to the report, “By 2025, the number of people in China aged 65 or over is expected to top 198 million.” You can be sure quite a few of those are going to get cancer.]]>
China Medical: A Cure For My Portfolio? http://seekingalpha.com/article/59223/comments?source=feed#comment-119045 119045 Mon, 25 Feb 2008 23:47:13 -0500 Sanderson Farms: 'Eat Mor Chikin' http://seekingalpha.com/article/63297/comments?source=feed#comment-114841 114841 Wed, 06 Feb 2008 08:09:30 -0500 China Medical: A Cure For My Portfolio? http://seekingalpha.com/article/59223/comments?source=feed#comment-108738 108738 Mon, 07 Jan 2008 12:46:41 -0500 China Medical: A Cure For My Portfolio? http://seekingalpha.com/article/59223/comments?source=feed#comment-108685 108685 Mon, 07 Jan 2008 09:31:04 -0500 Syneron's Fountain of Youth: An Attractive Buying Opportunity http://seekingalpha.com/article/54565/comments?source=feed#comment-104763 104763 Mon, 10 Dec 2007 12:06:26 -0500 seekingalpha.com/artic...

If CUTR is hurting, so is ELOS. P&G deal hasn't kicked in yet and when it does we still don't know what the new margins will be. There is still some downside potential ($14/$15 range) until Q4 results are in.

CrossProfit]]>